Profiling of cMET and HER Family Receptor Expression in Pancreatic Ductal Adenocarcinomas and Corresponding Lymph Node Metastasis to Assess Relevant Pathways for Targeted Therapies: Looking at the Soil Before Planting the Seed.

导出 LinkOut

翻译打印收藏纠错

作者： Alexander,Muckenhuber ^[1] ; Galina,Babitzki ; Marlene,Thomas ; Gabriele,Hölzlwimmer ; Magdalena,Zajac ; Moritz,Jesinghaus ; Frank,Bergmann ; Jens,Werner ; Albrecht,Stenzinger ; Wilko,Weichert

作者单位： From the *Institute of Pathology, University Hospital Heidelberg, Ruprecht-Karls Universität, Heidelberg; †Roche Pharma Research and Early Development, Roche Innovation Center, Penzberg, Germany; ‡AstraZeneca, Personalized Healthcare and Biomarkers, Innovative Medicines and Early Development, Cambridge, United Kingdom; §Department of Surgery, University Hospital Grosshadern, Ludwig-Maximilians-Universität, München, Germany; ∥National Center for Tumor Diseases, Heidelberg; and ¶German Cancer Consortium (DKTK), Dresden, Germany. ^[1]

主题词癌, 胰腺管(Carcinoma, Pancreatic Ductal);女(雌)性(Female);人类(Humans);淋巴结(Lymph Nodes);淋巴转移(Lymphatic Metastasis);原癌基因蛋白质c-met(Proto-Oncogene Proteins c-met)

DOI 10.1097/MPA.0000000000000604

PMID 26825865

发布时间 2018-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交